AstraZeneca announced today, May 8, the start of a global withdrawal procedure for its Covid-19 vaccine, after side effects were admitted.
The pharmaceutical company also communicated its intention to revoke the authorizations for the marketing of Vaxzevria in Europe, motivating this decision with the “excessive availability of updated versions of the vaccine”.
The EU agency advised against use of the vaccine, citing the wide availability of newer options. However, legal decisions become complex, with some families abandoning compensation claims.
Advertisements
AstraZeneca drew attention to itself today with the announcement of the global recall of its Covid-19 vaccine, known as Vaxzevria.
This move came after admissions of side effects, including the possibility of thrombosis, emerged in legal proceedings in London in late April.
The rare but serious side effect is known as thrombosis with thrombocytopenia or TTS. The rare syndrome occurred in approx two or three people out of 100 thousand vaccinated with Vaxzevria.
The European Medicines Agency recently advised against the use of the AstraZeneca vaccine, highlighting the abundance of newer alternatives adapted to variants of the virus. As a result, demand for Vaxzevria dropped dramatically, leading to the company ceasing production and supply.
However, the legal landscape around the vaccine continues to be complex. Some families involved in potential lawsuits have decided to withdraw, citing the challenges and costs associated with court battles. This raises important questions about the transparency and accountability of big pharmaceutical companies.
The global implications of this decision are significant. However, it remains to be seen how this move will affect public perception of vaccine safety and the future of the fight against the pandemic.
The withdrawal of the AstraZeneca vaccine has sparked a series of reactions in both the public health and legal worlds. As the company deals with the consequences of its decision, the debate over safety and liability continues to take center stage.
Nurse Times editorial team
Related articles
Find out how to earn money by publishing your thesis on NurseTimes
The NEXT project is renewed and becomes NEXT 2.0: we publish the questionnaires and your theses
Upload your thesis:tesi.nursetimes.org
Upload your questionnaire: https://tesi.nursetimes.org/questionari
